Form 4 for RANI Rani Therapeutics Holdings, Inc.
Accepted 2025-10-27 00:00:00 ET · period of report 2025-10-23 · accession 0001031686-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-27 | 2025-10-23 | RANI | IMRAN MIR A | Dir, 10% | P - Purchase | $0.61 | +2.08M | 2.08M | New | +$1.27M |
| D | 2025-10-27 | 2025-10-23 | RANI | IMRAN MIR A | Dir, 10% | P - Purchase | $0.00 | +2.08M | 2.08M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-10-23 | P | A | 2,083,334 | $0.61 | 2,083,334 | D | — | — | (F1) The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer. |
| 2 | Derivative | Warrant to Purchase Class A Common Stock | 2025-10-23 | P | A | 2,083,334 | $0.00 | 2,083,334 | D | $0.48 · — to — | 2,083,334 Class A Common Stock | (F4) The warrants shall be exercisable upon stockholder approval and have a term of exercise equal to five years from the date of such stockholder approval. |